- 2022.12.23
- Event TAGCyx will be attending 41st Annual J.P. Morgan Healthcare Conference
- 2022.10.31
- Patents, Articles & Conferences Announcement of presentation at the 43rd Annual Meeting of the Japanese Society for Apheresis (November 12, 2022)
- 2022.9.8
- News Release CAGE Bio and TAGCyx announced execution of a license agreement for development and commercialization of TAGX-0003 for the treatment of immunodermatology diseases mediated by the IFN-γ pathway
- 2022.7.13
- Event ‘The 3rd Aptamer Seminar in Tokyo ~virtual meeting~’ will be held on September 2, 2022.
- 2022.3.23
- News Release TAGCyx secured a grant funding from ‘Support Program for Orphan drug prior to the Designation’ of Japan Agency for Medical Research and Development (AMED).
